General Statement of Disclosure:

CONSULTING FEES/HONORARIA: King Pharmaceuticals, Inc. (now part of Pfizer - October 2010)(NONE) RESEARCH/RESEARCH GRANTS: CRICO(MODEST)

View Full Disclosure